m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0209)
| Name |
A939572
|
||||
|---|---|---|---|---|---|
| Synonyms |
1032229-33-6, A939572, 4-(2-chlorophenoxy)-N-[3-(methylcarbamoyl)phenyl]piperidine-1-carboxamide, 4-(2-chlorophenoxy)-N-(3-(methylcarbamoyl)phenyl)piperidine-1-carboxamide, 4-(2-CHLOROPHENOXY)-N-[3-[(METHYLAMINO)CARBONYL]PHENYL]-1-PIPERIDINECARBOXAMIDE, 1-Piperidinecarboxamide,4-(2-chlorophenoxy)-N-[3-[(methylamino)carbonyl]phenyl]-, CHEMBL469169, A 939572, A-939572, 4-(2-chlorophenoxy)-N-(3-(methylcarbamoyl)-phenyl)piperidine-1-carboxamide, 4-(2-Chlorophenoxy)-N-[3-(methylcarbamoyl)-phenyl]piperidine-1-carboxamide, SCHEMBL14554165, DTXSID40648006, GLXC-03463, BCP27670, EX-A3456, A 939572 - Bio-X trade mark, BDBM50261716, s9607, AKOS022179820, CS-0305, AC-36384, AS-73726, BA162794, BA300005, HY-50709, DB-002537, DB-014948, C71136, EN300-6745729, Z1511753827, stearoyl-CoA desaturase (SCD) inhibitor;SCD-inhibitor; A-939572; A 939572, (Z)-4-(2-chlorophenoxy)-N-(3-((Z)-hydroxy(methylimino)methyl)phenyl)piperidine-1-carbimidic acid
Click to Show/Hide
|
||||
| Structure |
 |
||||
|
3D MOL
|
|||||
| Formula |
C20H22ClN3O3
|
||||
| InChI |
InChI=1S/C20H22ClN3O3/c1-22-19(25)14-5-4-6-15(13-14)23-20(26)24-11-9-16(10-12-24)27-18-8-3-2-7-17(18)21/h2-8,13,16H,9-12H2,1H3,(H,22,25)(H,23,26)
|
||||
| InChIKey |
DPYTYQFYDLYWHZ-UHFFFAOYSA-N
|
||||
| PubChem CID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT02042 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | Protein mono-ADP-ribosyltransferase PARP10 (PARP10) | |
| Epigenetic Regulator | DNA (cytosine-5)-methyltransferase 1 (DNMT1) | |
| Regulated Target | Methyltransferase-like protein 3 (METTL3) | |
| Crosstalk relationship | DNA modification → m6A | |
| Disease | Cardiomegaly | |